Article
Rare cancer-specific mutations in PIK3CA show gain of function.
Proceedings of the National Academy of Sciences of the United States of America - 27 Mar 2007
Gymnopoulos Marco, Elsliger Marc-André, Vogt Peter K
Abstract excerpt
Fifteen rare cancer-derived mutants of PIK3CA, the gene coding for the catalytic subunit p110alpha of phosphatidylinositol 3-kinase (PI3K), were examined for their biological and biochemical properties. Fourteen of these mutants show a gain of function: they induce rapamycin-sensitive oncogenic transformation of chicken embryo fibroblasts, constitutively activate Akt and TOR-mediated signaling, and show enhanced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
